British Hospital Transforms Life-Changing Maxillofacial Surgeries With Stratasys 3D Printing
April 27 2017 - 8:00AM
Business Wire
- Stratasys 3D Printer at Queen Elizabeth
Hospital leads to cost savings in operating room (OR) time of up to
£20,000 per surgery
- In-house 3D printing capabilities
enable time saving of 93 percent in surgical planning time, and
time savings of three to four hours in OR time
- Stratasys PolyJet 3D printing is used
to construct advanced maxillofacial cutting guides and anatomical
models for patients with severe conditions, including facial and
cranial tumours
Stratasys Ltd. (Nasdaq:SSYS), the 3D printing and additive
manufacturing solutions company, today announced that its PolyJet
3D printing technology is helping to improve life-changing
maxillofacial surgeries at the Queen Elizabeth Hospital in
Birmingham, UK. Stratasys’ Objet Eden350V 3D Printer is deployed to
produce customized models for pre-surgical preparations, enabling a
reduction of up to 93 percent in surgical planning time associated
with standard anatomical models. Furthermore, the hospital reports
that three to four hours are saved in surgical time per surgery,
and costs are reduced by up to £20,000 per operation.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170427005845/en/
The hospital's Stratasys Objet Eden350V
3D Printer allows Consultant Maxillofacial Prosthetist Stefan
Edmondson and his team to save around three to four hours in OR
time per surgery (Photo: Stratasys)
Having previously outsourced its 3D printing requirements,
implementing an in-house 3D printer, with help of Tri-Tech 3D, has
revolutionised pre-surgical procedures across a number of
departments. This includes the maxillofacial (face and jaw); burns
and plastics; ear, nose and throat; and neurosurgery units.
“The ability to produce lifelike medical models in-house on our
Stratasys 3D Printer saves around three to four hours in OR time
per surgery, which at a cost of £5,000 an hour of operating room
time, is quite a substantial cost saving,” explains Stefan
Edmondson, Consultant Maxillofacial Prosthetist at the
hospital.
Changing entire procedures with 3D printing
Most of the patients currently benefiting from the hospital’s 3D
printing capability are trauma and cancer patients, typically those
with facial or cranial tumours. Using Stratasys 3D printing, the
maxillofacial prosthetic team converts patients’ CT scans into
highly accurate 3D printed replica models, bone replacement parts
or metal prosthetic plates that are customized to the exact
specification of each patient.
“If we need to remove bone from a patient’s face, we can produce
an exact 3D printed model to develop the cutting guides,” continues
Edmondson. “This process results in more efficient clinical
outcomes and saves the hospital, patient and medical practitioner
valuable time and associated costs.”
As well as facilitating the production of surgical cutting
guides to speed up extremely advanced procedures, Stratasys PolyJet
3D printing allows surgeons to practice surgeries on true-to-life
3D printed anatomical models. This provides invaluable insight into
procedural outcomes and helps minimize risks.
The unique properties of Stratasys’ materials are also integral
to the process, with the VeroWhite material providing a smooth,
high resolution finish ideal for accurate anatomical models. This
provides an invaluable reference material throughout
operations.
3D printing transforms surgical procedures for cancer
patients
“When dealing with severe cases whereby surgical plates hold
facial bones in place, we need absolute assurance that they fit the
patients’ measurements exactly,” continues Edmondson.
“3D printing a replica of the patient’s anatomy allows us to
pre-bend these plates in our laboratory. Having these capabilities
at the hospital streamlines the entire operation and ensures we are
100 percent prepared when heading into surgery.”
“The advances Queen Elizabeth Hospital is making in the use of
3D printing in surgical planning are remarkable,” says Scott Rader,
General Manager, Healthcare Solutions, Stratasys. “It is a clear
demonstration of the ability for 3D printing to enable physicians
to better plan, practice and determine the optimal surgical
approach. In the current operating climate, physicians need
solutions that can save time and money, while also improving
quality of care. Queen Elizabeth’s implementation of 3D printing
achieves these goals.”
For more than 25 years, Stratasys Ltd.
(NASDAQ:SSYS) has been a defining force and dominant player in
3D printing and additive manufacturing – shaping the way things are
made. Headquartered in Minneapolis, Minnesota and Rehovot, Israel,
the company empowers customers across a broad range of vertical
markets by enabling new paradigms for design and manufacturing. The
company’s solutions provide customers with unmatched design freedom
and manufacturing flexibility – reducing time-to-market and
lowering development costs, while improving designs and
communications. Stratasys subsidiaries include MakerBot and
Solidscape, and the Stratasys ecosystem includes 3D printers for
prototyping and production; a wide range of 3D printing materials;
parts on-demand via Stratasys Direct Manufacturing; strategic
consulting and professional services; and the Thingiverse and
GrabCAD communities with over 2 million 3D printable files for free
designs. With more than 2,700 employees and 1200 granted or pending
additive manufacturing patents, Stratasys has received more than 30
technology and leadership awards. Visit us online at:
www.stratasys.com or http://blog.stratasys.com/, and follow us on
LinkedIn.
Stratasys is a registered trademark and Fortus is a trademark of
Stratasys Ltd. and/or its subsidiaries or affiliates.
Attention Editors, if you publish reader-contact information,
please use:
- USA 1-877-489-9449
- Europe/Middle East/Africa
+49-7229-7772-0
- Asia Pacific +852 3944-8888
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170427005845/en/
StratasysArita Mattsoff, +972 (0)74 745 4000
(IL)arita@stratasys.comJoe Hiemenz, +1 952-906-2726
(US)joe.hiemenz@stratasys.comorNorth AmericaStratasysCraig
Librett, +1
518-424-2497Craig.Librett@stratasys.comorEuropeIncus
MediaJonathan Wake / Miguel Afonso, +44 1737
215200stratasys@incus-media.comorAsia
PacificStratasys APJanice Lai, +852 3944
8888Media.ap@stratasys.comorJapanStratasys JapanAya
Yoshizawa, +81 90 6473
1812aya.yoshizawa@stratasys.comorKoreaStratasys KoreaJihyun
Lee, +82 2 2046 2287Jihyun.lee@stratasys.comorGreater
ChinaStratasys ShanghaiJanice Lai, +852 3944
8888media.ap@stratasys.comorMexico, Central America, Caribe and
South AmericaStratasys MexicoYair Canedo, +52 55 4169
4181yair.canedo@stratasys.comorBrazilGPCOMClezia Martins
Gomes, +55 (11) 3129 5158clezia@gpcom.com.br
Stratasys (NASDAQ:SSYS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stratasys (NASDAQ:SSYS)
Historical Stock Chart
From Sep 2023 to Sep 2024